Concepedia

Tomoyuki Sumizawa

TS

87

Publications

5.3K

Citations

41

H-Index

1989

Active since

Affiliations

Kagoshima University(Current)

The University of Osaka

University of Occupational and Environmental Health Japan

Taiho Pharmaceutical (Japan)

Tomoyuki Sumizawa is an author at Kagoshima University specializing in medicine, pharmacology, and cell biology.

Top concepts

Publications per year

1989–2013

87

Publications

87

Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal Carcinoma

Y. Takebayashi, Shin‐ichi Akiyama, Suminori Akiba et al. · JNCI Journal of the National Cancer Institute · 1996 · 366 citations

Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.

Masanobu Komatsu, Tomoyuki Sumizawa, Masato Mutoh et al. · PubMed · 2000 · 333 citations

, , +15

The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.

Shigeto Matsushita, Takao Nitanda, Tatsuhiko Furukawa et al. · PubMed · 1999 · 209 citations

, , +17

Multidrug Resistance and the Lung Resistance-Related Protein in Human Colon Carcinoma SW-620 Cells

Masaki Kitazono, Tomoyuki Sumizawa, Yuji Takebayashi et al. · JNCI Journal of the National Cancer Institute · 1999 · 184 citations · Full text

Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.

Kazutaka Miyadera, Tomoyuki Sumizawa, Hiroki Yoshida et al. · PubMed · 1995 · 183 citations

Rows per page

1–5 of 87